Showing 9,601 - 9,620 results of 25,857 for search '(( via ((a decrease) OR (step decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.98s Refine Results
  1. 9601

    Effective degradation rate as a function of the age <i>a</i> of an mRNA. by Carlus Deneke (169004)

    Published 2013
    “…<p>The lifetime distribution of an mRNA can be translated into an age-dependent degradation rate via Eq. (4). Here, we illustrate the change of the degradation rate during the lifetime of an mRNA for the two decay patterns shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0055442#pone-0055442-g003" target="_blank">Fig. 3</a>. …”
  2. 9602
  3. 9603
  4. 9604

    Mitochondrial Inhibitor Rotenone Triggers and Enhances Neuronal Ferroptosis Following Intracerebral Hemorrhage by Yijun Cheng (10296278)

    Published 2023
    “…Ferroptosis, a form of regulatory non-apoptotic cell death driven by iron-dependent lipid peroxidation, accounts for more than 80% of the total types of neuronal death in the acute phase of intracerebral hemorrhage (ICH). …”
  5. 9605

    Mitochondrial Inhibitor Rotenone Triggers and Enhances Neuronal Ferroptosis Following Intracerebral Hemorrhage by Yijun Cheng (10296278)

    Published 2023
    “…Ferroptosis, a form of regulatory non-apoptotic cell death driven by iron-dependent lipid peroxidation, accounts for more than 80% of the total types of neuronal death in the acute phase of intracerebral hemorrhage (ICH). …”
  6. 9606

    Mitochondrial Inhibitor Rotenone Triggers and Enhances Neuronal Ferroptosis Following Intracerebral Hemorrhage by Yijun Cheng (10296278)

    Published 2023
    “…Ferroptosis, a form of regulatory non-apoptotic cell death driven by iron-dependent lipid peroxidation, accounts for more than 80% of the total types of neuronal death in the acute phase of intracerebral hemorrhage (ICH). …”
  7. 9607
  8. 9608

    Loss of <i>vap</i> alters starvation-induced autophagy-membrane biogenesis. by Marc Bourouis (6317045)

    Published 2019
    “…Mutant <i>vap</i><sup><i>1</i></sup> cells has non-fused green and red membranes (or vesicles) which are of larger sizes and wider distributions (green vesicles Mdn = 1,46 μm<sup>2</sup> in <i>vap1</i> vs 1,25 μm<sup>2</sup> in controls; red vesicles Mdn = 1,86 μm<sup>2</sup> in <i>vap1</i> vs 1,10 μm<sup>2</sup> in controls). …”
  9. 9609
  10. 9610

    AdING1b plus 5azaC significantly reduce tumor volume <i>in vivo</i> in a mouse xenograft model. by Satbir Thakur (141395)

    Published 2012
    “…<p>Approximately 7×10<sup>6</sup> MDA-MB468 cells/animal were injected into the mammary fat pads of mice and in two weeks when tumors reached a size of 5 mm ×5 mm ×5 mm, treatment was begun (green arrow at day one). Viral constructs (2×10<sup>8</sup> PFU, calculated to provide an MOI of 1–5) were injected intratumorally twice a week for 5 weeks (10 injections) and 5azaC was injected intraperitoneally three times a week for 5 weeks (15 injections). …”
  11. 9611
  12. 9612

    Food intake and body mass are reduced during diapause in <i>D. melanogaster (Canton S)</i>. by Olga I. Kubrak (659970)

    Published 2014
    “…<b>B</b> Body mass of whole flies was measured in flies corresponding to the sampling points in 2A. A significant decrease of body mass is seen already after one week of diapause (D1) compared to C1 controls, but no significant gain is seen after recovery from diapause (R1′, R1–R2). …”
  13. 9613
  14. 9614
  15. 9615

    UPR signaling can modulate <i>sa191</i> gain-of-function phenotype. by Lauren Klabonski (3386180)

    Published 2016
    “…<b>B</b>. Spliced XBP-1 (<i>xbp-1</i>s) rescues the decrease in SMAD::GFP fluorescence in <i>daf-28(sa191)</i> animals. …”
  16. 9616

    Exocytosis of ATP from astrocytes <i>in situ</i> can be triggered by synaptic stimulation. by Ulyana Lalo (506296)

    Published 2014
    “…The faster sEPSCs with larger amplitudes that underlie baseline activity both in wild-type and dn-SNARE mice are activated by ATP released from the nerve terminals. …”
  17. 9617

    Modification of the Phenotypes Caused by N-Terminal Expanded Htt in the <i>Drosophila</i> Eye by Linda S Kaltenbach (73472)

    Published 2007
    “…</p><p>The Htt-fragment-induced phenotype can be suppressed by (J) reduced levels of hu li tai shao <i>(GMR-GAL4</i>/P{lacW}hts<sup>k06121</sup>; <i>UAS:128Qhtt[M64]</i>/<i>+),</i> (K) reduced levels of G protein iαsubunit 65A <i>(GMR-GAL4</i>/; <i>UAS:128Qhtt[M64]</i>/P{SUPor-P}G-ia65A<sup>KG01907</sup>ry<sup>506</sup><i>),</i> (L) reduced levels of clathrin heavy chain <i>(</i>Chc<sup>1</sup>/+ <i>GMR-GAL4</i>/+; <i>UAS:128Qhtt[M64]</i>/<i>+),</i> (M) reduced levels of Rpt1 <i>(GMR-GAL4</i>/P{PZ}Rpt1<sup>05643</sup>cn<sup>1</sup>; <i>UAS:128Qhtt[M64]</i>/<i>+),</i> and (N) reduced levels of myocyte enhancing factor 2 <i>(GMR-GAL4</i>/Df(2R)X1,Mef2[X1]; <i>UAS:128Qhtt[M64]</i>/<i>+)</i>. …”
  18. 9618
  19. 9619

    Roadmap of the study protocol and procedures. by Amani Abu-Shaheen (4966288)

    Published 2025
    “…The device shows promise for clinical application, however, further research with larger sample sizes and human clinical trials are needed to validate its efficacy and safety. …”
  20. 9620

    Stop Nosebleeds device used to stop epistaxis. by Amani Abu-Shaheen (4966288)

    Published 2025
    “…The device shows promise for clinical application, however, further research with larger sample sizes and human clinical trials are needed to validate its efficacy and safety. …”